A review on anti-adhesion therapies of bacterial diseases.


Journal

Infection
ISSN: 1439-0973
Titre abrégé: Infection
Pays: Germany
ID NLM: 0365307

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 21 06 2018
accepted: 14 09 2018
pubmed: 3 10 2018
medline: 17 4 2019
entrez: 3 10 2018
Statut: ppublish

Résumé

Infections caused by bacteria are a foremost cause of morbidity and mortality in the world. The common strategy of treating bacterial infections is by local or systemic administration of antimicrobial agents. Currently, the increasing antibiotic resistance is a serious and global problem. Since the most important agent for infection is bacteria attaching to host cells, hence, new techniques and attractive approaches that interfere with the ability of the bacteria to adhere to tissues of the host or detach them from the tissues at the early stages of infection are good therapeutic strategies. All available national and international databanks were searched using the search keywords. Here, we review various approaches to anti-adhesion therapy, including use of receptor and adhesion analogs, dietary constituents, sublethal concentrations of antibiotics, and adhesion-based vaccines. Altogether, the findings suggest that interference with bacterial adhesion serves as a new means to fight infectious diseases. Anti-adhesion-based therapies can be effective in prevention and treatment of bacterial infections, but further work is needed to elucidate underlying mechanisms.

Sections du résumé

BACKGROUND BACKGROUND
Infections caused by bacteria are a foremost cause of morbidity and mortality in the world. The common strategy of treating bacterial infections is by local or systemic administration of antimicrobial agents. Currently, the increasing antibiotic resistance is a serious and global problem. Since the most important agent for infection is bacteria attaching to host cells, hence, new techniques and attractive approaches that interfere with the ability of the bacteria to adhere to tissues of the host or detach them from the tissues at the early stages of infection are good therapeutic strategies.
METHODS METHODS
All available national and international databanks were searched using the search keywords. Here, we review various approaches to anti-adhesion therapy, including use of receptor and adhesion analogs, dietary constituents, sublethal concentrations of antibiotics, and adhesion-based vaccines.
RESULTS RESULTS
Altogether, the findings suggest that interference with bacterial adhesion serves as a new means to fight infectious diseases.
CONCLUSION CONCLUSIONS
Anti-adhesion-based therapies can be effective in prevention and treatment of bacterial infections, but further work is needed to elucidate underlying mechanisms.

Identifiants

pubmed: 30276540
doi: 10.1007/s15010-018-1222-5
pii: 10.1007/s15010-018-1222-5
doi:

Substances chimiques

Anti-Infective Agents 0
Bacterial Vaccines 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

13-23

Commentaires et corrections

Type : ErratumIn

Références

Vaccine. 2007 Jun 28;25(27):5053-61
pubmed: 17532546
Carbohydr Res. 2009 Oct 12;344(15):1968-74
pubmed: 19665695
J Med Chem. 2012 May 24;55(10):4700-13
pubmed: 22519985
Infect Immun. 1993 Nov;61(11):4590-8
pubmed: 7691754
J Med Microbiol. 2012 Jan;61(Pt 1):101-108
pubmed: 21890513
Int J Oral Sci. 2011 Apr;3(2):66-73
pubmed: 21485310
Chemistry. 2011 Aug 29;17(36):10029-38
pubmed: 21774001
Microb Pathog. 2016 Sep;98:23-31
pubmed: 27338495
Invest Ophthalmol Vis Sci. 2011 Jul 01;52(7):4929-34
pubmed: 21467179
Biochim Biophys Acta. 2006 Apr;1760(4):527-37
pubmed: 16564136
Chembiochem. 2001 Dec 3;2(12):915-8
pubmed: 11948880
Infect Immun. 2000 Feb;68(2):796-800
pubmed: 10639448
Clin Exp Immunol. 1989 Sep;77(3):331-7
pubmed: 2478321
J Antimicrob Chemother. 2003 Feb;51(2):401-4
pubmed: 12562710
J Biomed Mater Res B Appl Biomater. 2008 Jul;86(1):36-44
pubmed: 18098186
Cell. 1997 Nov 14;91(4):511-20
pubmed: 9390560
BMJ. 2001 Jun 30;322(7302):1571
pubmed: 11431298
Trends Biotechnol. 2016 Jun;34(6):483-495
pubmed: 26875976
Chemistry. 2012 Apr 10;18(15):4522-32
pubmed: 22431310
Nat Rev Microbiol. 2015 May;13(5):269-84
pubmed: 25853778
Scand J Infect Dis Suppl. 1990;74:23-33
pubmed: 2097711
Mol Nutr Food Res. 2010 Dec;54(12):1744-52
pubmed: 20568234
J Agric Food Chem. 2013 Mar 20;61(11):2748-54
pubmed: 23428168
Annu Rev Nutr. 2005;25:37-58
pubmed: 16011458
Pediatr Res. 2006 Mar;59(3):377-82
pubmed: 16492975
J Antimicrob Chemother. 2006 Aug;58(2):439-43
pubmed: 16735419
Microb Pathog. 2016 Apr;93:22-31
pubmed: 26802522
J Med Food. 2011 Jul-Aug;14(7-8):739-45
pubmed: 21480803
Front Microbiol. 2017 Jul 11;8:1295
pubmed: 28744277
Lett Appl Microbiol. 2017 Nov;65(5):439-445
pubmed: 28857243
Curr Opin Biotechnol. 2012 Apr;23(2):160-7
pubmed: 21906930
Arch Oral Biol. 2010 Oct;55(10):754-62
pubmed: 20673869
Emerg Infect Dis. 1999 May-Jun;5(3):395-403
pubmed: 10341176
Food Funct. 2017 May 24;8(5):1955-1965
pubmed: 28470309
mBio. 2016 Oct 25;7(5):
pubmed: 27795393
Int J Antimicrob Agents. 2017 Aug;50(2):135-141
pubmed: 28689873
Clin Infect Dis. 2011 Jan 1;52(1):70-7
pubmed: 21148522
J Biol Chem. 1999 Aug 20;274(34):24316-20
pubmed: 10446208
Expert Rev Anti Infect Ther. 2009 Aug;7(6):683-6
pubmed: 19681694
J Med Chem. 2014 Feb 27;57(4):1416-27
pubmed: 24476493
Int J Food Microbiol. 2008 Jul 31;125(3):286-92
pubmed: 18524406
Biology (Basel). 2013 Sep 03;2(3):1135-49
pubmed: 24833058
Int J Antimicrob Agents. 2011 Jul;38(1):27-34
pubmed: 21570813
FEMS Microbiol Lett. 2006 May;258(1):1-8
pubmed: 16630247
Curr Drug Deliv. 2007 Apr;4(2):141-51
pubmed: 17456033
Int J Artif Organs. 2009 Sep;32(9):635-41
pubmed: 19882551
Phytother Res. 2011 Jun;25(6):828-32
pubmed: 21086548
N Engl J Med. 2003 May 29;348(22):2175-85
pubmed: 12637625
Lancet. 2000 Oct 21;356(9239):1398-402
pubmed: 11052582
Virulence. 2013 May 15;4(4):284-94
pubmed: 23799663
J Nutr. 2005 May;135(5):1304-7
pubmed: 15867329
Emerg Infect Dis. 2001 Jan-Feb;7(1):92-9
pubmed: 11266299
Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5977-82
pubmed: 16585510
Gut Pathog. 2009 Jul 09;1(1):14
pubmed: 19589170
Postgrad Med J. 2002 Sep;78(923):564-5
pubmed: 12357022
Biochem Int. 1991 Jul;24(4):749-56
pubmed: 1799374
Infect Immun. 2009 May;77(5):2065-75
pubmed: 19237519
Mol Microbiol. 2003 Jan;47(2):453-61
pubmed: 12519195
FEBS Lett. 2008 Mar 5;582(5):651-5
pubmed: 18242189
Biomed Pept Proteins Nucleic Acids. 1995;1(3):141-8
pubmed: 9346845
PLoS Comput Biol. 2018 May 3;14(5):e1006071
pubmed: 29723210
J Med Chem. 2014 Dec 26;57(24):10275-89
pubmed: 25419855
BMC Microbiol. 2011 Dec 14;11:263
pubmed: 22168812
Vaccine. 1993;11(2):213-200
pubmed: 8094931
Osong Public Health Res Perspect. 2017 Feb;8(1):54-60
pubmed: 28443224
J Nutr. 2014 Nov;144(11):1725-33
pubmed: 25143376
J Infect Dis. 2016 Feb 15;213(4):516-22
pubmed: 26401026
Nature. 1995 Oct 5;377(6548):435-8
pubmed: 7566121
Oral Microbiol Immunol. 2004 Jun;19(3):150-4
pubmed: 15107065
Appl Microbiol Biotechnol. 2010 Sep;88(2):451-9
pubmed: 20694794
BMC Infect Dis. 2010 Apr 14;10:94
pubmed: 20398248
Infect Immun. 1983 Jan;39(1):336-43
pubmed: 6337099
Gastroenterology. 2006 May;130(6):1688-95
pubmed: 16697733
Glycoconj J. 2010 Jan;27(1):89-97
pubmed: 19936918
Expert Rev Vaccines. 2007 Feb;6(1):47-56
pubmed: 17280478
Glycoconj J. 2000 Jul-Sep;17(7-9):659-64
pubmed: 11421356
Cell Microbiol. 2012 Feb;14(2):226-38
pubmed: 21999233
Mol Microbiol. 2005 Jan;55(2):441-55
pubmed: 15659162
Gut. 2000 Nov;47(5):646-52
pubmed: 11034580
J Ethnopharmacol. 2013 Jan 30;145(2):581-6
pubmed: 23220194
Chem Rev. 2015 Jan 14;115(1):525-61
pubmed: 25495138
J Biol Chem. 2001 Mar 30;276(13):9924-30
pubmed: 11134021
Microbiol Immunol. 2010 Apr;54(4):237-45
pubmed: 20377752
Gastroenterology. 1987 Oct;93(4):734-43
pubmed: 2442061
J Infect Dis. 2008 Aug 15;198(4):571-5
pubmed: 18613794
Crit Rev Food Sci Nutr. 2002;42(3 Suppl):279-84
pubmed: 12058986
FEBS Lett. 1987 Jun 15;217(2):145-57
pubmed: 2885220
Am J Physiol Lung Cell Mol Physiol. 2002 Apr;282(4):L751-6
pubmed: 11880301
Immunol Cell Biol. 2000 Feb;78(1):80-8
pubmed: 10651933
J Appl Microbiol. 2007 Nov;103(5):1828-37
pubmed: 17953593
Cell Microbiol. 2002 May;4(5):257-71
pubmed: 12027955
Mater Sci Eng C Mater Biol Appl. 2017 Jan 1;70(Pt 1):753-762
pubmed: 27770951
Expert Rev Anti Infect Ther. 2012 Dec;10(12):1457-68
pubmed: 23253323
Science. 1997 Apr 25;276(5312):607-11
pubmed: 9110982
Can J Microbiol. 1992 Sep;38(9):983-5
pubmed: 1464071
BMC Res Notes. 2016 Jan 13;9:25
pubmed: 26758445
FEMS Immunol Med Microbiol. 2003 Oct 15;38(3):181-91
pubmed: 14522453
ACS Nano. 2017 Feb 28;11(2):2160-2170
pubmed: 28151647
Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17897-902
pubmed: 17098869
Am Rev Respir Dis. 1993 Jul;148(1):201-7
pubmed: 8317800
J Agric Food Chem. 2010 Nov 24;58(22):11662-6
pubmed: 21038921
Proc Natl Acad Sci U S A. 2011 Feb 22;108(8):3348-53
pubmed: 21300870
Virulence. 2012 Jul 1;3(4):389-99
pubmed: 22722243
Microb Pathog. 2011 Nov;51(5):373-7
pubmed: 21782926
Nat Microbiol. 2016 Oct 26;1(11):16186
pubmed: 27782138
Vet Dermatol. 2008 Aug;19(4):221-5
pubmed: 19086121
Lancet. 2002 May 25;359(9320):1829-31
pubmed: 12044380
Int J Antimicrob Agents. 2007 Jun;29(6):700-4
pubmed: 17382520
N Engl J Med. 1996 Feb 8;334(6):341-8
pubmed: 8538704
Clin Vaccine Immunol. 2010 Dec;17(12):1859-67
pubmed: 20980482

Auteurs

Arezoo Asadi (A)

Department of Microbiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Shabnam Razavi (S)

Department of Microbiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran. razavi.sh@iums.ac.ir.

Malihe Talebi (M)

Department of Microbiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Mehrdad Gholami (M)

Department of Microbiology and Virology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH